Business Description
MD Medical Group Investments PLC
ISIN : US55279C2008
Share Class Description:
LSE:MDMG: DRDescription
MD Medical Group Investments PLC is a private healthcare provider in Russia. The company has a vertically integrated business model supported by technological and educational initiatives. The group operates in a diversified format both in terms of the range of services offered to clients and price policy, including multidisciplinary clinical hospitals, consultative and diagnostic centers, outpatient clinics in Moscow and regions, and the MD LAB laboratory network. It specializes in women's and children's healthcare. The company's services include obstetrics and gynecology, pediatrics, fertility and in vitro fertilization (IVF) treatment, and other services, including laboratory services, stem cell storage, trauma, rehabilitation, dental care, and surgery, among other services.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.37 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 28.81 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.81 | |||||
| Beneish M-Score | -2.62 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.5 | |||||
| 3-Year EBITDA Growth Rate | 12.8 | |||||
| 3-Year EPS without NRI Growth Rate | 20.5 | |||||
| 3-Year FCF Growth Rate | 91 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 26.86 | |||||
| Days Sales Outstanding | 11.15 | |||||
| Days Payable | 65.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 15.21 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.66 | |||||
| Operating Margin % | 26.25 | |||||
| Net Margin % | 26.38 | |||||
| FCF Margin % | 26.44 | |||||
| ROE % | 24.81 | |||||
| ROA % | 19.25 | |||||
| ROIC % | 22.34 | |||||
| ROC (Joel Greenblatt) % | 27.88 | |||||
| ROCE % | 23.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.42 | |||||
| PE Ratio without NRI | 7.42 | |||||
| Shiller PE Ratio | 8.68 | |||||
| Price-to-Owner-Earnings | 6.75 | |||||
| PEG Ratio | 0.61 | |||||
| PS Ratio | 1.15 | |||||
| PB Ratio | 1.16 | |||||
| Price-to-Tangible-Book | 1.24 | |||||
| Price-to-Free-Cash-Flow | 4.36 | |||||
| Price-to-Operating-Cash-Flow | 3.32 | |||||
| EV-to-EBIT | 3.43 | |||||
| EV-to-EBITDA | 2.79 | |||||
| EV-to-Revenue | 0.96 | |||||
| EV-to-FCF | 3.62 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Median-PS-Value | 0.35 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.48 | |||||
| Price-to-Graham-Number | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 15.41 | |||||
| Price-to-Net-Cash | 114 | |||||
| Earnings Yield (Greenblatt) % | 29.15 | |||||
| FCF Yield % | 22.96 | |||||
| Forward Rate of Return (Yacktman) % | 21.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MD Medical Group Investments PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 371.817 | ||
| EPS (TTM) ($) | 0.768 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 5.7 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 2.5 - 5.7 | ||
| Shares Outstanding (Mil) | 75.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MD Medical Group Investments PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MD Medical Group Investments PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MD Medical Group Investments PLC Frequently Asked Questions
What is MD Medical Group Investments PLC(LSE:MDMG)'s stock price today?
The current price of LSE:MDMG is $5.70. The 52 week high of LSE:MDMG is $5.70 and 52 week low is $2.50.
When is next earnings date of MD Medical Group Investments PLC(LSE:MDMG)?
The next earnings date of MD Medical Group Investments PLC(LSE:MDMG) is 2024-09-11 Est..
Does MD Medical Group Investments PLC(LSE:MDMG) pay dividends? If so, how much?
MD Medical Group Investments PLC(LSE:MDMG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers